LSI USA

The ABCs of LSI USA ‘26 — Today’s letter of the day is H for “Hospital Guide.” Leading health systems play a critical role in shaping which innovations succeed and how quickly they reach patients. This discussion focused on how hospitals are approaching partnerships with startups and strategics more intentionally, from early validation through commercialization. Panelists shared how they evaluate new technologies, structure collaborations that actually move forward, and align clinical priorities with business outcomes to drive real adoption. “Innovating with Intention: The Hospitals’ Guide to Working with Startups and Strategics” featured: • Peter Slavin, MD — President and CEO, Cedars-Sinai Medical Center and Health System • Chris Coburn — Chief Innovation Officer, Mass General Brigham Tune in each day as we recap LSI USA ‘26 from A to Z. Want to join us at our next event? Registration is open for our next three events: • LSI Asia ‘26 in Singapore | June 30 - July 2, 2026 • LSI Europe ‘26 in Barcelona | September 28 - October 1, 2026 • LSI USA ‘27 in Dana Point | March 15 - 19, 2027 Learn more and register on our website. #LSIUSA26

The ABCs of LSI USA ‘26 — Today’s letter of the day is G for “How to Identify a Product Line or Category of Investment.” Investors and strategics are constantly deciding where to focus capital across expanding product lines and emerging categories. This discussion explored how they define investment priorities, assess category potential, and determine which platforms warrant deeper conviction. Panelists shared how they think about portfolio construction, risk concentration, adjacency strategies, and timing, and how early-stage companies can understand where they fit within these broader investment frameworks. “How to Identify a Product Line or Category of Investment” featured: • Tal Wenderow — Managing Partner, Star51 Capital • Matt McBride — General Partner, Wave Strategy • Tamir Meiri — Principal, Venture Investments, Johnson & Johnson • Jessica Clayton — Sr. Director, Technology Incubation, Siemens Healthineers • Aaron Johnson — Director Corporate Business Development, Stryker Tune in each day as we recap LSI USA ‘26 from A to Z. Want to join us at our next event? Registration is open for our next three events: • LSI Asia ‘26 in Singapore | June 30 - July 2, 2026 • LSI Europe ‘26 in Barcelona | September 28 - October 1, 2026 • LSI USA ‘27 in Dana Point | March 15 - 19, 2027 Learn more and register on our website. #LSIUSA26

The ABCs of LSI USA ‘26: Today’s letter of the day is H Here are the presenting companies who took the stage that start with the letter H: • Halsted AI — Dani Kiyasseh, DPhil • HapticHeart Solutions — Christopher Lee • HD Medical Group — Arvind Thiagarajan • Healing Innovations, Inc. — Luke Benda • HeartPoint Global Inc. — Elena Amin, MBChB • Helico Technologies — Lukas Lindenroth • Hemanext — Daan Kok • HemaSense — Nathan Friedman • HEMEO — Leslie DeGeer • Hemogenyx Pharmaceuticals — Vladislav Sandler • Horao Neurolabs — Rutger Zietsma • Hy2Care® BV — Leo Smit Tune in each day as we recap LSI USA ‘26 from A to Z. Want to join us at our next event? Registration is open for our next three events: • LSI Asia ‘26 in Singapore | June 30 - July 2, 2026 • LSI Europe ‘26 in Barcelona | September 28 - October 1, 2026 • LSI USA ‘27 in Dana Point | March 15 - 19, 2027 Learn more and register on our website. #LSIUSA26

The ABCs of LSI USA ‘26 — Today’s letter of the day is G for “GLP-1.” The rise of GLP-1 therapies is reshaping more than just obesity care. It is starting to ripple across the entire medtech landscape. This session explored how sustained weight loss, changing patient profiles, and shifting treatment pathways could impact everything from surgical volumes to device demand. The conversation focused on where devices remain essential, where they may be displaced, and where new opportunities are emerging alongside this rapidly evolving therapeutic category. “The GLP-1 Effect: What the Obesity Revolution Means for Medical Devices” featured: • Emmy Jedras — FastnAlign • Lloyd Diamond — Nitinotes Surgical • Susan Johnson MBA, BA, RN — Magellan Medical Technology Consultants, Inc. • Jeff Chandler — KiriGenX Inc. Tune in each day as we recap LSI USA ‘26 from A to Z. Want to join us at our next event? Registration is open for our next three events: • LSI Asia ‘26 in Singapore | June 30 - July 2, 2026 • LSI Europe ‘26 in Barcelona | September 28 - October 1, 2026 • LSI USA ‘27 in Dana Point | March 15 - 19, 2027 Learn more and register on our website. #LSIUSA26

The ABCs of LSI USA ‘26: Today’s letter of the day is G Here are the presenting companies who took the stage that start with the letter G: • Galenband — Eddie McDaid • GelSana — Melissa Krebs, Ph.D. • GenesisTissue Inc. — Katie Weimer • Glucotrack — Paul Goode • GRIP Molecular Technologies, Inc — Bruce Batten • GuideAI Health — Raj P. Shah MD, MBA • GuideStar Medical Devices — Mike Dolphin • Gyder Surgical — Sujit Dike Tune in each day as we recap LSI USA ‘26 from A to Z. Want to join us at our next event? Registration is open for our next three events: • LSI Asia ‘26 in Singapore | June 30 - July 2, 2026 • LSI Europe ‘26 in Barcelona | September 28 - October 1, 2026 • LSI USA ‘27 in Dana Point | March 15 - 19, 2027 Learn more and register on our website. #LSIUSA26

The ABCs of LSI USA ‘26 — Today’s letter of the day is F for “Fogarty Innovation.” On Day 2 of LSI USA ‘26, Andrew Cleeland opened the day with a tribute to Dr. Thomas J. Fogarty, founder of Fogarty Innovation, who passed away peacefully on December 28, 2025, at the age of 91. Tom dedicated his career to improving patient care. A cardiovascular surgeon and a gifted engineer, Tom had an innate ability to envision practical solutions to the problems he observed at the bedside. As an innovator and entrepreneur, his relentless pursuit of “a better way,” fueled numerous inventions that fundamentally changed surgical practice. These include the industry-standard Fogarty balloon embolectomy catheter, which transformed what had been a high-morbidity, high-mortality open procedure for removing blood clots in the legs into a minimally invasive approach; the Hancock Tissue Heart Valve; and the AneuRx Endovascular Aortic Stent Graft, among many others. Today, under the leadership of CEO Andrew Cleeland, Fogarty Innovation continues his legacy by mentoring the next generation of innovators, strengthening the medtech ecosystem through education and alliances, and upholding his “patient first” philosophy in all that we do. Read Andrew Cleeland’s full message on Dr. Fogarty in Fogarty’s February newsletter: https://lnkd.in/g-dng5Kr — Tune in each day as we recap LSI USA ‘26 from A to Z. #LSIUSA26

The ABCs of LSI USA ‘26 — Today’s letter of the day is F for “Federal Opportunities for Medtech Scale.” Federal pathways are often overlooked, but they can be a powerful lever for medtech companies looking to scale. This session unpacked how non-dilutive funding, government partnerships, and federal commercialization programs can help companies accelerate growth without relying solely on traditional venture capital. The discussion focused on how to navigate these channels effectively, align with agency priorities, and turn early traction into long-term scale. “Bootstrapping to Billions: Leveraging Federal Opportunities for Medtech Scale” featured: • Nick Pachuda — Precision Life Science Partners • George Davis — StrategicFeds, LLC • Konrad Dobschuetz — Leap Advisory & Intelligence • Jason Frye — Terrapin • George Godfrey — StrategicFeds Tune in each day as we recap LSI USA ‘26 from A to Z. Want to join us at our next event? Registration is open for our next three events: • LSI Asia ‘26 in Singapore | June 30 - July 2, 2026 • LSI Europe ‘26 in Barcelona | September 28 - October 1, 2026 • LSI USA ‘27 in Dana Point | March 15 - 19, 2027 Learn more and register on our website. #LSIUSA26

The ABCs of LSI USA ‘26 — Today’s letter of the day is F for “Fireside Chats.” To kick off LSI USA ‘26, we opened with two Fireside Chats on the Botanical Lawn, overlooking the Pacific as the sun set. 1. Opening Fireside Chat with Dr. Omar Ishrak, Former Chairman and CEO of Medtronic and Chairman of Qubit Health Capital, in conversation with Dr. Jean N., Founder at Stealth Robotics Co and Managing Partner at Qubit Health Capital. 2. “Opening Fireside Chat: How Deep Tech is Reshaping a More Human Future of Healthcare,” featuring Tim Draper, Founder and Managing Partner of Draper Associates, and Dr. Nicholas Theodore, MD, FACS, FAANS, Professor and Chairman of Neurosurgery at the University of Arizona College of Medicine-Phoenix. There was no better way to set the tone for the week. Tune in each day as we recap LSI USA ‘26 from A to Z. Want to join us at our next event? Registration is open for our next three events: • LSI Asia ‘26 in Singapore | June 30 - July 2, 2026 • LSI Europe ‘26 in Barcelona | September 28 - October 1, 2026 • LSI USA ‘27 in Dana Point | March 15 - 19, 2027 Learn more and register on our website. #LSIUSA26

The ABCs of LSI USA ‘26: Today’s letter of the day is F Here are the presenting companies who took the stage that start with the letter F: • Field Medical — Steven Mickelsen • Field Orthopaedics — Patryk J. Kania • Flow Medical — Jennifer Fried • Fluid Biomed Inc. — John Wong • Flux Robotics 🧲 — Christoff Heunis • FoxEyes Corporation — Haariss Ilyas, MD FAAOS • Freyya — Gabriele Niederauer, PhD • Fundamental XR — Richard Vincent Tune in each day as we recap LSI USA ‘26 from A to Z. Want to join us at our next event? Registration is open for our next three events: • LSI Asia ‘26 in Singapore | June 30 - July 2, 2026 • LSI Europe ‘26 in Barcelona | September 28 - October 1, 2026 • LSI USA ‘27 in Dana Point | March 15 - 19, 2027 Learn more and register on our website. #LSIUSA26

The ABCs of LSI USA ‘26 — Today’s letter of the day is E for “Eko Health.” At LSI USA ‘26, we welcomed Eko Health Co-Founder & CEO, Connor Landgraf, to share the story of how they reimagined the stethoscope, transforming it from a 200-year-old tool into an AI-powered platform that is changing the way clinicians detect heart and lung disease. Eko has raised over $100M to date and is scaling globally, making early detection of heart and lung disease more accessible than ever. “Building Eko Health, AI, and the Future of Connected Care ” featured: • Connor Landgraf — Co-Founder & CEO, Eko Health • Henry Peck — Chief Business Officer, LSI Tune in each day as we recap LSI USA ‘26 from A to Z. Want to join us at our next event? Registration is open for our next three events: • LSI Asia ‘26 in Singapore | June 30 - July 2, 2026 • LSI Europe ‘26 in Barcelona | September 28 - October 1, 2026 • LSI USA ‘27 in Dana Point | March 15 - 19, 2027 Learn more and register on our website. #LSIUSA26